State regulators monitor compounded weight-loss drug production and distribution due to increased demand and patient safety concerns.

Compounded weight-loss drugs, such as Wegovy, are rising in popularity due to supply shortages and insurance issues. Patients seeking cheaper alternatives turn to compounded versions of these medications. However, the increased demand for these drugs has become a growing concern for state regulators, who are now monitoring their production and distribution to ensure patient safety.

July 08, 2024
3 Articles